Panasonic Corp (6752.T)

6752.T on Tokyo Stock Exchange

1,495JPY
27 Feb 2015
Change (% chg)

¥38 (+2.61%)
Prev Close
¥1,457
Open
¥1,469
Day's High
¥1,498
Day's Low
¥1,465
Volume
16,610,300
Avg. Vol
9,305,524
52-wk High
¥1,610
52-wk Low
¥1,030

6752.T

Chart for 6752.T

About

Panasonic Corporation is a Japan-based company. The Appliance segment is engaged in the development, manufacture and sale of white goods, beauty and living appliance, healthy products, among others. The Eco Solution segment is engaged in the development, manufacture and sale of lighting fixtures, lamps, lighting devices, wiring... (more)

Overall

Beta: 1.37
Market Cap(Mil.): ¥3,549,569.00
Shares Outstanding(Mil.): 2,453.05
Dividend: 8.00
Yield (%): 1.11

Financials

  6752.T Industry Sector
P/E (TTM): 187.55 53.84 19.66
EPS (TTM): 7.72 -- --
ROI: 0.65 1.30 14.32
ROE: 1.05 -0.24 11.60
Search Stocks

TABLE-Panasonic -2014/15 div forecast

Feb 27 - Panasonic Corp CONSOLIDATED EARNINGS ESTIMATES (in billions of yen unless specified) Full year to Full year to Mar 31, 2015 Mar 31, 2015 LATEST PREVIOUS FORECAST FORECAST Annual Div 18.00 yen -Q4 Div 10.00 yen NOTE - Panasonic Corpis one of world

27 Feb 2015

Fitch: Sony Commits to Focus on Higher Profitability, at Last

(The following statement was released by the rating agency) HONG KONG/SYDNEY, February 23 (Fitch) Fitch Ratings says Sony Corporation's (Sony; BB-/Stable) new mid-term strategy to prioritise significant profitability improvements is credit positive because low margins are the key reason that the company is rated significantly lower than during its heyday. However, rating upgrades will depend on management's ability to successfully execute this strategy and deliver sustained profitability an

23 Feb 2015

UPDATE 1-TowerJazz 4th-quarter profit doubles, tops estimates

* Shares up 7 pct in Tel Aviv (Adds quotes from CEO, details, share price)

23 Feb 2015

TowerJazz Q4 profit doubles, tops estimates

TEL AVIV, Feb 23 - Israeli chipmaker TowerJazz beat estimates for fourth-quarter net profit on revenue from its joint venture in Japan with Panasonic Corp as well as growing market share from its largest customers.

23 Feb 2015

Bayer diabetes business sale not imminent: sources

FRANKFURT - German drugmaker Bayer is in talks to sell its diabetes devices division but a sale is not imminent, two sources with knowledge of the matter told Reuters.

20 Feb 2015

UPDATE 1-Bayer diabetes business sale not imminent -sources

* Contour made sales of 722 million in 2013 (Recasts, adds sources, changes dateline to Frankfurt)

20 Feb 2015

Bayer may sell diabetes devices unit to KKR-backed Panasonic Health -report

TOKYO, Feb 20 - German drugmaker Bayer AG is close to selling its diabetes devices business to KKR-backed Panasonic Healthcare Holdings Co Ltd and the unit could be valued at up to $2.3 billion, Bloomberg news reported.

19 Feb 2015

PHILIPPINES PRESS-Asian markets key to Panasonic's sales growth goal-Inquirer

Japan's Panasonic Corp. is counting on economically promising Asian markets such as the Philippines to help it meet its target of hitting 10 trillion yen in sales by fiscal year 2018, company officials said, the Philippine Daily Inquirer reported.

17 Feb 2015

Fitch Revises Panasonic's Outlook to Positive; Affirms at 'BBB-'

(The following statement was released by the rating agency) HONG KONG/SYDNEY/SINGAPORE, February 13 (Fitch) Fitch Ratings has affirmed Panasonic Corporation's (Panasonic) Long-Term Foreign- and Local-Currency Issuer Default Ratings (IDRs) of 'BBB-'. The Outlook has been revised to Positive from Stable. A full list of rating actions is at the end of this release. The Outlook revision reflects Fitch's expectations that Panasonic's streamlined business structure and coherent strategy would furt

13 Feb 2015

EU mergers and takeovers (Feb 12)

BRUSSELS, Feb 12 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

12 Feb 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$169.00
Provider: Wright Reports
$169.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks